SNWV Stock Analysis: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$10.82
0.32 (3.05%)
▲
5d:
+9.85%
30d:
-29.69%
90d:
-36.76%
BUY
HIGH Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 14, 2026
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SNWV shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SNWV shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.96
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $10.82, which is considered fair relative to its 30-day fair value range of $8.95 to $14.71. The stock's valuation (Forward PE: 29.2) is in line with its historical norms (28.7). At these levels, the market is pricing in 0.6% annual earnings growth.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $14.52. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+269.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $14.52. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+269.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.95 -
$14.71
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.0%)
- BULLISH: Trading 269.7% below Wall St target ($40.00)
- BULLISH: Expecting earnings turnaround to 0.6% growth with 3.1% revenue growth
Trading Range Analysis
30-Day Trading Range
$8.95 -
$14.71
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$14.52
Resistance Level
$17.07
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.24
Wall Street Target
$40.00
(+269.7%)
Revenue Growth (YoY)
3.1%
Earnings Growth (YoY)
-99.6%
Profit Margin
37.2%
Valuation Premium vs History
+0.6% premium
PE vs Historical
29.2 vs 28.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$10.88
(+1%)
2-Year Target
$10.95
(+1%)
3-Year Target
$11.02
(+2%)
3-Yr Target (if PE normalizes)
(PE: 29→29)
PE COMPRESSION
$10.81
(0%)
Earnings growth offset by PE compression
📈
Valuation based on Current Earnings
Trailing PE: 10.94 | Current EPS (TTM): $0.96
Bull Case
$5.78
(-47%)
Analyst growth -50.0%, PE expands to 12.0
Base Case
$5.25
(-52%)
Market implied -50.0%, PE stable at 10.9
Bear Case
$7.14
(-34%)
Severe decline -20.0%, PE contracts to 9.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 08, 2026 1:22 AM ET
Data refreshes hourly during market hours. Next update: 2:22 AM
Data refreshes hourly during market hours. Next update: 2:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 64 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 64 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 67 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 60 HOLD |
